I have 30 years of experience, and specialize in the field of preclinical drug development with specific knowledge in the areas of GPCRs, opiate pharmacology and peptides in general. I have published on such topics as GPCRs, basic pharmacology and peptide therapeutics. Was involved in cloning the opiate receptors and this lead to the development of a company that specializes in developing novel analgesics.